Beta Bionics, Inc. (BBNX) Operating Expenses (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Operating Expenses data on file, last reported at $40.7 million in Q1 2026.

• Quarterly Operating Expenses rose 47.42% year-over-year to $40.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $140.3 million (up 52.35% YoY) and the FY2025 annual result came in at $127.2 million, up 56.79% from the prior year.
• Operating Expenses grew to $40.7 million in Q1 2026 per BBNX's latest filing, from $35.1 million in the prior quarter.
• The five-year high for Operating Expenses was $40.7 million in Q1 2026, with the low at $16.7 million in Q1 2024.
• Average Operating Expenses over 3 years is $27.7 million, with a median of $27.6 million recorded in 2025.
• The widest YoY moves for Operating Expenses: up 65.8% in 2025, down 41.83% in 2025.
• Beta Bionics' Operating Expenses stood at $24.7 million in 2024, then jumped by 41.83% to $35.1 million in 2025, then gained by 16.08% to $40.7 million in 2026.
• Business Quant data shows BBNX's Operating Expenses at $40.7 million in Q1 2026, $35.1 million in Q4 2025, and $32.2 million in Q3 2025.